CRMP4 has been reported to be involved in the metastatic process of tumor cells [15, 18], and the expression level of CRMP4 in GC tissues may represent a promising biomarker for the malignant behavior of gastric cancer. This evidence concerns the gene DPYSL3 and gastric cancer.